Robert Weinberg, MD | |
10755 Falls Rd, Lutherville, MD 21093-4515 | |
(410) 583-2800 | |
Not Available |
Full Name | Robert Weinberg |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 55 Years |
Location | 10755 Falls Rd, Lutherville, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205872579 | NPI | - | NPPES |
799901100 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | D04835 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Johns Hopkins University | 8921903147 | 2692 |
News Archive
A new study published on the preprint server medRxiv in May 2020 reports a model that could help evolve appropriate dosage protocols for future clinical trials of the repurposed drug nitazoxanide in COVID-19 prevention and treatment. The researchers say, "It was possible to achieve plasma and lung tizoxanide concentrations, using proven safe doses of nitazoxanide, that exceed the EC90 for SARS-CoV-2."
Acetylon Pharmaceuticals, Inc. announced today that it has closed on a $2 million investment from a new undisclosed private investor to bring its total financing to $9.25 million. This new investment will convert to stock in the next substantial round of preferred equity financing.
A recent study published in the July 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that early intervention, beginning between 18 and 30 months of age improves outcomes for children with autism spectrum disorder (ASD) at age 6.
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.
› Verified 4 days ago
Entity Name | Johns Hopkins University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
A new study published on the preprint server medRxiv in May 2020 reports a model that could help evolve appropriate dosage protocols for future clinical trials of the repurposed drug nitazoxanide in COVID-19 prevention and treatment. The researchers say, "It was possible to achieve plasma and lung tizoxanide concentrations, using proven safe doses of nitazoxanide, that exceed the EC90 for SARS-CoV-2."
Acetylon Pharmaceuticals, Inc. announced today that it has closed on a $2 million investment from a new undisclosed private investor to bring its total financing to $9.25 million. This new investment will convert to stock in the next substantial round of preferred equity financing.
A recent study published in the July 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that early intervention, beginning between 18 and 30 months of age improves outcomes for children with autism spectrum disorder (ASD) at age 6.
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Robert Weinberg, MD Po Box 64481, Baltimore, MD 21264-4481 Ph: (410) 583-2802 | Robert Weinberg, MD 10755 Falls Rd, Lutherville, MD 21093-4515 Ph: (410) 583-2800 |
News Archive
A new study published on the preprint server medRxiv in May 2020 reports a model that could help evolve appropriate dosage protocols for future clinical trials of the repurposed drug nitazoxanide in COVID-19 prevention and treatment. The researchers say, "It was possible to achieve plasma and lung tizoxanide concentrations, using proven safe doses of nitazoxanide, that exceed the EC90 for SARS-CoV-2."
Acetylon Pharmaceuticals, Inc. announced today that it has closed on a $2 million investment from a new undisclosed private investor to bring its total financing to $9.25 million. This new investment will convert to stock in the next substantial round of preferred equity financing.
A recent study published in the July 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that early intervention, beginning between 18 and 30 months of age improves outcomes for children with autism spectrum disorder (ASD) at age 6.
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.
› Verified 4 days ago
Dr. Pranav Hemant Patel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1209 York Rd, Lutherville, MD 21093 Phone: 410-821-9490 | |
David Guyton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10755 Falls Rd, Lutherville, MD 21093 Phone: 410-583-2800 | |
Michael H Grodin, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1209 York Rd, Suite 200, Lutherville, MD 21093 Phone: 410-821-9490 Fax: 410-821-9495 | |
Susan B Bressler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10755 Falls Rd, Lutherville, MD 21093 Phone: 410-583-2800 | |
Jonathan Katz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1209 York Rd, Lutherville, MD 21093 Phone: 410-821-9490 | |
Nakul Singh Shekhawat, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10755 Falls Rd Ste 110, Lutherville, MD 21093 Phone: 410-583-2762 Fax: 410-583-2716 |